Back

AchieveCE

  • Hantavirus Infections
  • Influenza, Human
  • Leptospirosis
  • Palliative Care

Hantavirus Infection, Recognition, Triage, and Modern Management

Hantavirus infection carries a 30 50% case fatality rate even with optimal intensive care, and the way it reaches clinicians has changed. This course covers how Andes virus and other hantaviruses cause disease; the prodromal and crisis-phase features that set them apart; common mimics such as leptospirosis and influenza; triage and infection control; and evidence-based supportive care. Drawing on the 2018 Epuyén and 2026 MV Hondius outbreaks, which demonstrated person-to-person transmission of Andes virus in close-contact settings, it centers on the recognition decisions made at triage and during the prodrome, when early diagnosis saves lives and protects healthcare workers. By the end, learners will be able to take a focused exposure history, place hantavirus on the differential early, distinguish it from look-alike illnesses, implement appropriate isolation and testing, and deliver or support evidence-based management. This course addresses a specific gap: most clinical training still frames Hantavirus as a rodent-only, rural disease, leaving clinicians unprepared to recognize it in returning travelers, cruise- or expedition-exposed patients, and close contacts during the prodromal phase exactly when timely history-taking, isolation, and testing change outcomes. Most clinical training still teaches Hantavirus as a rodent-borne disease tied to rural environmental exposure. That framing leaves clinicians unprepared to recognize Hantavirus in returning travelers, patients with outbreak-associated cruise or expedition exposure, and close contacts of confirmed cases, especially during the prodromal phase when diagnosis matters most. The 2018 Epuyén outbreak in Argentina and the 2026 MV Hondius outbreak both showed documented person-to-person transmission of Andes virus under close-contact conditions, including healthcare worker infections when isolation was delayed. With a 30 50% case fatality rate, even with optimal intensive care, recognition cannot wait for crisis-phase findings. This course updates traditional teaching to match current epidemiology so clinicians can take the right exposure history, order the right tests, and isolate early enough to change outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Paid

This provider typically $19–30

See fees on achievece.com

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • Paid · this provider typically $19–30
  • Released
    Jul 4, 2026
  • Last day to claim credit
    Jul 5, 2029 3 years left